MRKR

Marker Therapeutics, Inc. [MRKR] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

MRKR Stock Summary

Top 10 Correlated ETFs

MRKR


Top 10 Correlated Stocks

MRKR


In the News

12:30 28 Mar 2024 MRKR

Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

HOUSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that Juan Vera, M.D., President and Chief Executive Officer of Marker Therapeutics, will present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference. This conference will be held virtually on March 26, 2024.

08:00 28 Mar 2024 MRKR

Marker Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference

HOUSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that Juan F. Vera, M.D., President and Chief Executive Officer, will present at the H.C. Wainwright 25th Annual Global Investment Conference, which is being held on September 11-13, 2023 at the Lotte New York Palace Hotel in New York City.

06:00 28 Mar 2024 MRKR

Utilizing Fundamental Analysis for Your Penny Stocks? 3 Tips

Penny stocks, often defined as shares trading for less than $5, present a unique opportunity for investors seeking high potential returns. Despite their low market price, these stocks can offer significant upside potential, particularly when approached with a well-informed strategy.

11:59 28 Mar 2024 MRKR

Why Is Marker Therapeutics (MRKR) Stock Up 27% Today?

Marker Therapeutics (NASDAQ: MRKR ) stock is rising higher on Wednesday as investors react to positive pre-clinical news from the clinical-stage immuno-oncology company. Today's results come from a test of MT-601 in lymphoma cells.

12:10 28 Mar 2024 MRKR

7 Low Float Penny Stocks To Watch After SNTG Stock Explodes

More low float penny stocks to watch. The post 7 Low Float Penny Stocks To Watch After SNTG Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

06:48 28 Mar 2024 MRKR

MARKER THERAPEUTICS, INC. (MRKR) Reports Q3 Loss, Tops Revenue Estimates

MARKER THERAPEUTICS, INC. (MRKR) delivered earnings and revenue surprises of 38.46% and 393.75%, respectively, for the quarter ended September 2022.

12:53 28 Mar 2024 MRKR

3 Hot Penny Stocks To Buy For Under $1 Right Now

If you're watching the action in the stock market today, you're seeing plenty of chop. The U.S. dollar's strength has pushed broader markets lower, but a mix of positive and negative economic against this week's PPI data and CPI data has brought much more push-pull action.

04:05 28 Mar 2024 MRKR

Marker Therapeutics to Present at Two Upcoming March Investor Conferences

HOUSTON, March 07, 2022 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc.  (NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that Anthony H. Kim, Chief Financial Officer of Marker Therapeutics, will present at two upcoming investor conferences in March.

01:08 28 Mar 2024 MRKR

Why Are Marker Therapeutics Shares Trading Lower On Thursday?

Marker Therapeutics Inc (NASDAQ: MRKR) shares are trading lower after Roth Capital downgrades the company from Buy to Neutral and lowers the price target from $3 to $1. The company reported initial results from the Phase 2 trial for MT-401 as a treatment option for Acute myeloid leukemia (AML) in the post-transplant setting.

07:03 28 Mar 2024 MRKR

3 Penny Stocks Under $1 For You List This Week

Penny stocks to watch today The post 3 Penny Stocks Under $1 For You List This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

MRKR Financial details

Company Rating
Sell
Market Cap
43.65M
Income
-9.34M
Revenue
10.57M
Book val./share
1.89
Cash/share
1.98
Dividend
-
Dividend %
-
Employees
67
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-4.68
Forward P/E
-0.99
PEG
0.58
P/S
4.17
P/B
2.62
P/C
2.19
P/FCF
-2.14
Quick Ratio
6.32
Current Ratio
7.01
Debt / Equity
-0.14
LT Debt / Equity
-
-
-
EPS (TTM)
-1.09
EPS next Y
-4.4
EPS next Q
1.58
EPS this Y
-34.55%
EPS next Y
303.67%
EPS next 5Y
413.76%
EPS last 5Y
-45.93%
Revenue last 5Y
112.87%
Revenue Q/Q
-66.22%
EPS Q/Q
-217.24%
-
-
-
-
SMA20
16.8%
SMA50
-6.61%
SMA100
64.36%
Inst Own
0.8%
Inst Trans
1.72%
ROA
-48%
ROE
-52%
ROC
-0.97%
Gross Margin
68%
Oper. Margin
-154%
Profit Margin
-88%
Payout
-
Shs Outstand
8.89M
Shs Float
6.41M
-
-
-
-
Target Price
-
52W Range
0.67-9.68
52W High
-
52W Low
-
RSI
50.79
Rel Volume
0.65
Avg Volume
24.61K
Volume
16.03K
Perf Week
0.46%
Perf Month
3.83%
Perf Quarter
19.89%
Perf Half Y
-9.77%
-
-
-
-
Beta
1.485
-
-
Volatility
0.22%, 0.33%
Prev Close
0.46%
Price
4.34
Change
-9.58%

MRKR Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.110.050.10.161.08
Net income per share
-77.5-4.46-6.06-5.47-3.58
Operating cash flow per share
-7.58-4.01-4.01-3.57-3.23
Free cash flow per share
-7.66-4.09-6.23-3.97-3.82
Cash per share
32.349.634.545.541.41
Book value per share
31.089.675.815.752.35
Tangible book value per share
31.089.675.815.752.35
Share holders equity per share
31.089.675.815.752.35
Interest debt per share
00.112.611.550.91
Market cap
105.96M131.29M68.21M72.7M22.21M
Enterprise value
44.21M87.87M59.11M42.21M18.04M
P/E ratio
-0.72-6.46-2.39-1.74-0.74
Price to sales ratio
514.38615.84146.1258.542.47
POCF ratio
-7.32-7.18-3.62-2.66-0.82
PFCF ratio
-7.24-7.04-2.33-2.39-0.7
P/B Ratio
1.792.982.491.651.13
PTB ratio
1.792.982.491.651.13
EV to sales
214.63412.17126.64342
Enterprise value over EBITDA
-0.3-3.95-2.12-1.16-0.69
EV to operating cash flow
-3.05-4.81-3.13-1.55-0.67
EV to free cash flow
-3.02-4.71-2.02-1.39-0.57
Earnings yield
-1.4-0.15-0.42-0.58-1.35
Free cash flow yield
-0.14-0.14-0.43-0.42-1.44
Debt to equity
00.010.450.270.39
Debt to assets
00.010.270.170.22
Net debt to EBITDA
0.421.950.330.840.16
Current ratio
22.1122.833.813.562.14
Interest coverage
00001.98K
Income quality
0.10.850.660.650.9
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
118.3546.822.4310.411.42
Research and developement to revenue
601.9559.8740.4522.382.9
Intangibles to total assets
00000
Capex to operating cash flow
0.010.020.550.110.18
Capex to revenue
-0.72-1.76-22.34-2.52-0.55
Capex to depreciation
0-1.31-9.69-0.99-1.34
Stock based compensation to revenue
79.3725.1311.24.80.59
Graham number
232.831.1528.1626.6113.75
ROIC
-2.49-0.47-0.55-0.58-0.86
Return on tangible assets
-2.38-0.44-0.63-0.61-0.87
Graham Net
30.929.140.712.38-0.15
Working capital
59.19M43.49M18.01M33.08M8.84M
Tangible asset value
59.34M44.09M27.34M43.99M19.6M
Net current asset value
59.19M43.21M6.14M21.83M1.8M
Invested capital
00.010.450.270.39
Average receivables
54.09K82.18K528.37K500.4K1.2M
Average payables
1.32M1.31M1.96M4.04M3.38M
Average inventory
00-500K-500K0
Days sales outstanding
191.6896.2782.380.0797.37
Days payables outstanding
028.3956.74593.67159.87
Days of inventory on hand
00-19.3300
Receivables turnover
1.93.790.475.24K3.75
Payables turnover
012.856.430.612.28
Inventory turnover
00-18.8800
ROE
-2.49-0.46-1.04-0.95-1.53
Capex per share
-0.08-0.08-2.22-0.41-0.59

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.350.720.40.090.03
Net income per share
-0.82-0.48-0.560.29-0.34
Operating cash flow per share
-0.91-0.75-0.68-0.81-0.13
Free cash flow per share
-0.93-0.77-0.69-0.8-0.13
Cash per share
2.161.410.732.081.98
Book value per share
2.72.341.822.181.89
Tangible book value per share
2.72.341.822.181.89
Share holders equity per share
2.72.341.822.181.89
Interest debt per share
0.930.890.850-0.26
Market cap
30.83M22.27M6.19M27.04M40.07M
Enterprise value
20.47M18.1M7.28M8.91M22.6M
P/E ratio
-1.13-1.39-0.322.69-3.36
Price to sales ratio
10.453.681.7735.45155.55
POCF ratio
-4.03-3.53-1.05-3.83-35.54
PFCF ratio
-3.98-3.46-1.03-3.89-35.54
P/B Ratio
1.361.140.391.422.4
PTB ratio
1.361.140.391.422.4
EV to sales
6.942.992.0811.6987.71
Enterprise value over EBITDA
-3.42-6.27-1.78-2.16-7.06
EV to operating cash flow
-2.68-2.87-1.24-1.26-20.04
EV to free cash flow
-2.64-2.81-1.21-1.28-20.04
Earnings yield
-0.22-0.18-0.790.09-0.07
Free cash flow yield
-0.25-0.29-0.97-0.26-0.03
Debt to equity
0.340.390.470-0.14
Debt to assets
0.190.220.270-0.12
Net debt to EBITDA
1.731.44-0.274.385.46
Current ratio
1.992.142.17.527.01
Interest coverage
-70.3727.7860.1500
Income quality
1.11.641.192.10.38
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
1.250.310.723.35.48
Research and developement to revenue
2.470.872.083.127.94
Intangibles to total assets
00000
Capex to operating cash flow
0.010.020.02-0.020
Capex to revenue
-0.03-0.02-0.030.150
Capex to depreciation
-0.1-0.13-0.1200
Stock based compensation to revenue
0.510.120.19-0.160.68
Graham number
7.045.014.793.763.79
ROIC
-0.18-0.11-0.160.03-0.22
Return on tangible assets
-0.17-0.12-0.170.11-0.15
Graham Net
0.1-0.15-0.521.891.67
Working capital
11.14M8.84M5.71M19.03M16.71M
Tangible asset value
22.6M19.6M15.91M19.03M16.71M
Net current asset value
3.91M1.8M-1.11M19.03M16.71M
Invested capital
0.340.390.470-0.14
Average receivables
1.15M2.04M2.24M1.91M914.71K
Average payables
1.89M1.82M2.24M2.23M1.95M
Average inventory
00-500K-500K0
Days sales outstanding
51.2935.7153.56206.0529.11
Days payables outstanding
174.51150.3476.3160.190
Days of inventory on hand
00-26.6500
Receivables turnover
1.752.521.680.443.09
Payables turnover
0.520.61.181.50
Inventory turnover
00-3.3800
ROE
-0.3-0.2-0.310.13-0.18
Capex per share
-0.01-0.02-0.010.010

MRKR Frequently Asked Questions

What is Marker Therapeutics, Inc. stock symbol ?

Marker Therapeutics, Inc. is a US stock , located in Houston of Tx and trading under the symbol MRKR

What is Marker Therapeutics, Inc. stock quote today ?

Marker Therapeutics, Inc. stock price is $4.34 today.

Is Marker Therapeutics, Inc. stock public?

Yes, Marker Therapeutics, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap